WHO ICTRP trial
The OPG/RANKL/RANK system: implication for osteoporosis and atherosclerosis…
EUCTR2007-005618-38-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2007-005618-38-IT |
|---|---|
| Public title | The OPG/RANKL/RANK system: implication for osteoporosis and atherosclerosis development. Potential role of the treatment with Atorvastatin - ND |
| Scientific title | The OPG/RANKL/RANK system: implication for osteoporosis and atherosclerosis development. Potential role of the treatment with Atorvastatin - ND |
| Primary sponsor | U.L.S.S. 9 DI TREVISO |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Italy |
| Conditions | Osteoporosis in hypercholesterolemic patients MedDRA version: 9.1 Level: LLT Classification code 10031282 Term: Osteoporosis |
| Interventions | Trade Name: TORVAST Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Atorvastatin Concentration unit: g gram(s) Concentration type: equal Concentration number: .04- |
| Registration date | May 2, 2008 |
| Secondary IDs | OPG/RANKL/RANK/1 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: